ビオフェルミン製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2019/06/28 | 日証協 | 20,800株 | +2.97% | 1,400株 | -76.27% | 80,469株 | -0.25% | 2,200株 | -35.93% |
2019/06/21 | 日証協 | 20,200株 | -7.76% | 5,900株 | +13.46% | 80,669株 | -47.93% | 3,434株 | -31.32% |
2019/06/14 | 日証協 | 21,900株 | +13.47% | 5,200株 | +100% | 154,935株 | -0.58% | 5,000株 | +163.16% |
2019/06/07 | 日証協 | 19,300株 | +6.04% | 2,600株 | +4% | 155,835株 | -3.17% | 1,900株 | -45.71% |
2019/05/31 | 日証協 | 18,200株 | -2.67% | 2,500株 | 0% | 160,935株 | +0.12% | 3,500株 | +600% |
2019/05/24 | 日証協 | 18,700株 | -13.02% | 0株 | -100% | 160,735株 | -0.86% | 500株 | -89.36% |
2019/05/17 | 日証協 | 21,500株 | -12.24% | 1,500株 | -82.14% | 162,130株 | +1.95% | 4,700株 | -96.51% |
2019/05/10 | 日証協 | 24,500株 | +17.79% | 8,400株 | +265.22% | 159,030株 | -2.46% | 134,695株 | +8318.44% |
2019/04/26 | 日証協 | 20,800株 | -16.55% | 2,300株 | -56.6% | 163,035株 | -2.99% | 1,600株 | 0% |
2019/04/19 | 日証協 | 24,925株 | -19.92% | 5,300株 | +8.16% | 168,060株 | -5.67% | 1,600株 | +14.12% |
2019/04/12 | 日証協 | 31,125株 | +0.32% | 4,900株 | -46.74% | 178,158株 | -1.66% | 1,402株 | -61.15% |
2019/04/05 | 日証協 | 31,025株 | +4.37% | 9,200株 | -42.5% | 181,160株 | +2.1% | 3,609株 | -97.74% |
2019/03/29 | 日証協 | 29,725株 | +61.33% | 16,001株 | +283.17% | 177,442株 | +592.27% | 159,718株 | +2239.85% |
2019/03/22 | 日証協 | 18,425株 | +17.92% | 4,176株 | +4.4% | 25,632株 | +4.91% | 6,826株 | +520.55% |
2019/03/15 | 日証協 | 15,625株 | +5.4% | 4,000株 | +400% | 24,432株 | +1.24% | 1,100株 | -75.61% |
2019/03/08 | 日証協 | 14,825株 | -18.66% | 800株 | -79.49% | 24,132株 | -7.3% | 4,510株 | +0.76% |
2019/03/01 | 日証協 | 18,225株 | +13.73% | 3,900株 | -15.22% | 26,032株 | -1.88% | 4,476株 | +135.58% |
2019/02/22 | 日証協 | 16,025株 | +1.33% | 4,600株 | +39.39% | 26,532株 | +0.38% | 1,900株 | -48.68% |
2019/02/15 | 日証協 | 15,815株 | +6.75% | 3,300株 | -24.83% | 26,432株 | +2.33% | 3,702株 | -30.26% |
※株式分割は考慮していませんのでご注意ください。